Diagnostic value of dual-time-point 18F-fluorodeoxyglucose PET/computed tomography in differentiating benign and malignant extrahepatic bile duct occupying lesions
Fubo LiObjective
To investigate the diagnostic value of dual-time-point 18 F-fluorodeoxyglucose (FDG) PET/computed tomography (CT) in characterizing extrahepatic bile duct occupying lesions.
Methods
A retrospective analysis was performed on 157 patients with suspected extrahepatic bile duct occupying lesions who underwent dual-time-point
18
F-FDG PET/CT at the Affiliated Hospital of Chengde Medical University between January 2021 and February 2026. According to lesion nature, patients were divided into a malignant group and a benign group. The Mann–Whitney
Results
Among the 157 patients with suspected extrahepatic bile duct occupying lesions, 126 cases (80.2%) were malignant and 31 cases (19.8%) were benign. Compared with the benign group, the malignant group showed statistically significant differences in jaundice (yes/no), intrahepatic bile duct dilatation (yes/no), extrahepatic bile duct dilatation (yes/no), CA19-9, retention index, maximum standard uptake value, early lesion-to-liver ratio (LLR), and delayed LLR (all
Conclusion
Dual-time-point 18 F-FDG PET/CT combined with CA19-9 and jaundice (yes/no) has important value in diagnosing the nature of extrahepatic bile duct occupying lesions.